Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2026-03-05 @ 4:55 PM
Study NCT ID:
NCT03152292
Status:
TERMINATED
Last Update Posted:
2021-08-06
First Post:
2017-05-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study
Sponsor:
ACADIA Pharmaceuticals Inc.
Organization:
Study Overview
Official Title:
Management of Parkinson's Disease Psychosis in Actual Practice (The INSYTE Study)
Status:
TERMINATED
Status Verified Date:
2021-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study follow-up duration impacted by COVID-19pandemic and Sponsor terminated for business reasons
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To examine the current disease progression of PDP, the clinical, economic, and humanistic impact of anti-psychotic therapy in the management of the condition in real-world settings, and the burden of the condition on patients and their caregivers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: